Cognitive Peptide Research Overview
Neuropeptide research focused on cognition examines how small peptide molecules modulate neurotrophic factor expression, neurotransmitter tone, and synaptic plasticity. Selank and Semax represent two of the most characterized compounds in this area โ each with distinct primary mechanisms and overlapping secondary effects on learning and stress-related neural activity in preclinical models.
Both compounds were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and have been subjects of peer-reviewed research since the 1990s, giving them one of the longer published research histories of any nootropic peptide class.
Selank: Anxiolytic and Immunomodulatory Research
Origin and Structure
Selank is a heptapeptide (TKPRPGP) synthesized as an analogue of the endogenous tuftsin immunopeptide (Thr-Lys-Pro-Arg), with a Pro-Gly-Pro extension appended to enhance its stability and CNS bioavailability. This structural modification allows Selank to resist rapid enzymatic degradation โ a key property for neuropeptide research utility.
Mechanism of Action
Selank's primary documented effects in preclinical models involve modulation of the GABAergic system and serotonergic tone. Studies have reported changes in GABA-A receptor subunit expression and increases in serotonin turnover in relevant brain regions. Additionally, Selank has been associated with BDNF (Brain-Derived Neurotrophic Factor) upregulation in hippocampal tissue โ a finding that has generated significant interest given BDNF's established role in memory consolidation and synaptic plasticity.
In rodent anxiety models (elevated plus maze, open field test), Selank has consistently demonstrated anxiolytic-like behavioral effects without the sedation or motor impairment associated with classical GABA-A modulators โ a profile that distinguishes it mechanistically from benzodiazepine compounds.
Semax: ACTH Fragment and BDNF Research
Origin and Structure
Semax is a heptapeptide (MEHFPGP) derived from a fragment of the adrenocorticotropic hormone (ACTH 4-7) with a Pro-Gly-Pro stabilizing extension โ the same structural motif used in Selank's design. Despite sharing this extension, Semax and Selank originate from entirely different endogenous parent sequences and have distinct primary mechanisms.
Mechanism of Action
Semax's most replicated preclinical finding is its robust upregulation of BDNF and NGF (Nerve Growth Factor) in the hippocampus and frontal cortex. These neurotrophins are critical regulators of neuronal survival, synaptogenesis, and long-term potentiation โ the cellular mechanism underlying memory formation.
Semax has also been studied for its effects on the dopaminergic and serotonergic systems, with reported increases in dopamine and serotonin turnover in relevant brain regions. In cognitive performance paradigms in rodent models, Semax has shown improvements in spatial memory, attention, and conditioned reflex learning โ making it one of the more frequently cited research neuropeptides for cognition endpoints.
Selank vs Semax: Comparative Research Profile
| Property | Selank | Semax |
|---|---|---|
| Parent sequence | Tuftsin analogue (TKPRPGP) | ACTH 4-7 analogue (MEHFPGP) |
| Primary mechanism | GABAergic / serotonergic modulation | BDNF / NGF upregulation |
| Anxiolytic profile | Strong โ primary research focus | Moderate secondary effect |
| Cognitive / memory | Moderate โ via BDNF | Strong โ primary research focus |
| Neurotrophic activity | BDNF secondary effect | BDNF + NGF primary effect |
| Immunomodulatory | Yes โ tuftsin lineage | Limited |
| Key models | Elevated plus maze, stress models | Morris water maze, avoidance learning |
Combined Neuropeptide Research Protocols
Given their mechanistic complementarity โ Selank primarily targeting GABAergic/anxiolytic pathways and Semax targeting neurotrophic/cognitive pathways โ combined Selank + Semax protocols have been explored for comprehensive neuropeptide interaction studies. The distinct mechanisms make confounding effects less likely than in compounds with shared primary targets.
Purity Standards
Storage Guidelines
| Form | Storage | Shelf Life |
|---|---|---|
| Lyophilized (unopened) | โ20ยฐC freezer | 24+ months |
| Lyophilized (opened) | โ20ยฐC freezer | 12 months |
| Reconstituted | 2โ8ยฐC refrigerator | 30 days |
Frequently Asked Questions
What is the difference between Selank and Semax in cognitive research?
Selank's primary research focus is anxiolytic-like activity via GABAergic and serotonergic modulation, with secondary BDNF effects. Semax's primary focus is BDNF and NGF upregulation for cognitive and memory research, with secondary anxiolytic properties. They are mechanistically complementary rather than overlapping.
Where can researchers in the USA buy Selank and Semax?
Evo Peptides (evopeptidesus.com) carries both Selank and Semax as research-only compounds with third-party COA verification and same-day shipping before 3 PM CST from Wisconsin.
For research use only. Order Selank at evopeptidesus.com and Semax at evopeptidesus.com.